Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2026 | YOCAS, mood disturbance and insomnia in cancer survivors

Karen Mustian • 30 May 2026
ASCO 2026
General

Karen Mustian, PhD, University of Rochester Medical Center, Rochester, NY, presents findings from a Phase III trial examining Yoga for Cancer Survivors (YOCAS), mood disturbance and insomnia in cancer survivors. Results show that the intervention improves mood disturbance, anxiety and fatigue, which mediates a reduction in insomnia. This interview took place during the 2026 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Karen Mustian

Does YOCAS produce long-term benefits in mood disturbances and insomnia in cancer survivors?
0:45
Does YOCAS produce long-term benefits in mood disturbances and insomnia in cancer survivors?
Karen Mustian • 30 May 2026
Implementation of YOCAS into a clinical setting
2:32
Implementation of YOCAS into a clinical setting
Karen Mustian • 30 May 2026
Improving patients' circadian rhythm with yoga
0:57
Improving patients' circadian rhythm with yoga
Karen Mustian • 25 Aug 2016
The importance of exercise in treating cancer-related fatigue
4:30
The importance of exercise in treating cancer-related fatigue
Karen Mustian • 25 Aug 2016

Related Videos

Does YOCAS produce long-term benefits in mood disturbances and insomnia in cancer survivors?
0:45
Does YOCAS produce long-term benefits in mood disturbances and insomnia in cancer survivors?
Karen Mustian • 30 May 2026
Implementation of YOCAS into a clinical setting
2:32
Implementation of YOCAS into a clinical setting
Karen Mustian • 30 May 2026
Can steroid use as antiemetic prophylaxis be avoided in pediatric and adolescent patients?
1:00
Can steroid use as antiemetic prophylaxis be avoided in pediatric and adolescent patients?
Venkatraman Radhakrishnan • 30 May 2026
WTS for fusion detection in solid tumors: SCRUM-Japan MONSTAR-SCREEN-2
1:33
WTS for fusion detection in solid tumors: SCRUM-Japan MONSTAR-SCREEN-2
Takao Fujisawa • 1 Jun 2026
The content of VJOncology is intended for healthcare professionals